Clinical trial

Combination Chemotherapy With or Without Dexrazoxane in Treating Children With…

NCT00005578 · Children's Oncology Group, Other · Completed

Key facts

NCT number NCT00005578
Title Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
Official title Advanced Stage Hodgkins Disease - A Pediatric Oncology Group Phase III Study
Lead sponsor Children's Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cardiac Toxicity, Lymphoma
Intervention type Biological, Drug, Radiation
Interventions bleomycin sulfate, filgrastim, cyclophosphamide, dexrazoxane hydrochloride, doxorubicin hydrochloride, etoposide, prednisone, vincristine sulfate, radiation therapy
Enrollment 219
Start date Mar 1, 1997
Primary completion Oct 1, 2004
Completion Jun 1, 2008
First posted May 26, 2004
Last update posted Jul 24, 2014
Countries Canada, Switzerland, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies